These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Study design and rationale of the 'Balloon-Expandable Cobalt Chromium SCUBA Stent versus Self-Expandable COMPLETE-SE Nitinol Stent for the Atherosclerotic ILIAC Arterial Disease (SENS-ILIAC Trial) Trial': study protocol for a randomized controlled trial. Choi WG; Rha SW; Choi CU; Kim EJ; Oh DJ; Cho YH; Park SH; Lee SJ; Hur AY; Ko YG; Park SM; Kim KC; Kim JH; Kim MW; Kim SM; Bae JH; Bong JM; Kang WY; Seo JB; Jung WY; Cho JH; Kim do H; Ahn JH; Kim SH; Jang JY; Trials; 2016 Jun; 17(1):302. PubMed ID: 27344435 [TBL] [Abstract][Full Text] [Related]
10. Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease. Faries P; Jaff M; Peeters P; Khatib Y; Roberts D; Bosiers M; Malik R; Ravin R; Rundback J Ann Vasc Surg; 2018 Aug; 51():37-47. PubMed ID: 29678649 [TBL] [Abstract][Full Text] [Related]
11. Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions. Burket MW; Brodmann M; Metzger C; Tan K; Jaff MR J Vasc Interv Radiol; 2016 Nov; 27(11):1650-1656.e1. PubMed ID: 27542591 [TBL] [Abstract][Full Text] [Related]
12. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. Mwipatayi BP; Sharma S; Daneshmand A; Thomas SD; Vijayan V; Altaf N; Garbowski M; Jackson M; J Vasc Surg; 2016 Jul; 64(1):83-94.e1. PubMed ID: 27131926 [TBL] [Abstract][Full Text] [Related]
14. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203 [TBL] [Abstract][Full Text] [Related]
15. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease. Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972 [TBL] [Abstract][Full Text] [Related]
16. Balloon-Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: 9-Month Results from the BOLSTER Multicenter Study. Laird JR; Zeller T; Holden A; Scheinert D; Moore E; Mendes R; Schmiedel R; Settlage R; Lansky A; Jaff MR; J Vasc Interv Radiol; 2019 Jun; 30(6):836-844.e1. PubMed ID: 30956077 [TBL] [Abstract][Full Text] [Related]
17. Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee: 12-Month Clinical and Imaging Outcomes. Varcoe RL; Schouten O; Thomas SD; Lennox AF JACC Cardiovasc Interv; 2016 Aug; 9(16):1721-8. PubMed ID: 27539693 [TBL] [Abstract][Full Text] [Related]
18. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort. Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T; JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631 [TBL] [Abstract][Full Text] [Related]
19. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results. Stahlhoff S; Donas KP; Torsello G; Osada N; Herten M J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767 [TBL] [Abstract][Full Text] [Related]
20. Pivotal Study of a Next-Generation Balloon-Expandable Stent-Graft for Treatment of Iliac Occlusive Disease. Bismuth J; Gray BH; Holden A; Metzger C; Panneton J; J Endovasc Ther; 2017 Oct; 24(5):629-637. PubMed ID: 28697693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]